https saf.wellsfargoadvisors.com emx dctm research asg dsip abc_emx_dsip.pdf Rolling Performance Results Form DDD-1426AFORPF - Fill Out,
Description
Who should avoid AHK-Cu Individuals with copper metabolism disorders, specifically Wilson disease or Menkes disease, should not use copper peptides without medical guidance

The vial is sealed well, and the solution mixed perfectly with my peptide powder
Ignite your metabolism

For example, alternating between 7.5 mg and 10 mg weekly can provide an effective average dose of approximately 8.75 mg
doi: 10.1001/jama.295.21.2516